Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors
- DOI
- 10.1001/jamaoncol.2026.1924
- Published
- 2026-08-01
- Container
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1001/jamaoncol.2026.1924,
title = {Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors},
author = {Lucy Haggstrom and Yeh Chen Lee and Maria-Pilar Barretina-Ginesta and Anna Jaeger and Linn Woelber and Hannah Woopen and Madeline Rhind and Jean-Sébastien Frenel and Aanum Aanum and Katharina Bischof and Marta Mongillo and Allison L. Brodsky and Jonathan Ledermann and Talayeh S. Ghezelayagh and Ingrid Boere and Sabrina Kaiser and Constanza Maximiano and Ora Rosengarten and Tamar Safra and Ana Pertejo and Sabrina Cecere and Isabelle Ray-Coquard and Stephanie Lheureux and Ros Glasspool and Marta Gil-Martin and Laura Tookman and Se Ik Kim and Suzana Mittelstadt and Miguel Corbellas Aparicio and Isabel Palacio and Cristina Martin-Lorente and Rebecca Kristeleit and Helena de la Cueva and Nelleke Ottevanger and Maria Quindós Varela and Hiroyuki Yoshida and Theresa Link and Lydia Gaba and Gloria Marquina and Nikki Burdett and Paul Johannet and Juliane Reichenbach and Tjoung-Won Park-Simon and Philip H. Klecker and Antonio González-Martín and Christian Marth and Clemens Liebrich and Levan Dzotsenidze and Sabine Heublein and Lawrence Kasherman and Cristina Perez and Maria Masvidal and Pau Guillén Sentís and Nikolaus de Gregorio and Franziska Hemptenmacher and Felix Hilpert and Jalid Sehouli and Clare Scott and Katherine Mary Tucker and Jack Dong and Cristina Fortuno and Amanda B. Spurdle and Michael Friedlander and Unknown and Susan Ellard and Anna Tinker and Andrew Clamp and Iain McNeish and Nicoletta Colombo and Sandro Pignata and Kristina Lindemann and Patricia Roxburgh and Jae-Weon Kim and Shannon Westin and Jonathan Berek and William Tew and Carol Aghajanian and Philipp Harter},
year = {2026},
journal = {JAMA Oncology},
doi = {10.1001/jamaoncol.2026.1924},
url = {https://doi.org/10.1001/jamaoncol.2026.1924}
}RIS
TY - JOUR TI - Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors AU - Lucy Haggstrom AU - Yeh Chen Lee AU - Maria-Pilar Barretina-Ginesta AU - Anna Jaeger AU - Linn Woelber AU - Hannah Woopen AU - Madeline Rhind AU - Jean-Sébastien Frenel AU - Aanum Aanum AU - Katharina Bischof AU - Marta Mongillo AU - Allison L. Brodsky AU - Jonathan Ledermann AU - Talayeh S. Ghezelayagh AU - Ingrid Boere AU - Sabrina Kaiser AU - Constanza Maximiano AU - Ora Rosengarten AU - Tamar Safra AU - Ana Pertejo AU - Sabrina Cecere AU - Isabelle Ray-Coquard AU - Stephanie Lheureux AU - Ros Glasspool AU - Marta Gil-Martin AU - Laura Tookman AU - Se Ik Kim AU - Suzana Mittelstadt AU - Miguel Corbellas Aparicio AU - Isabel Palacio AU - Cristina Martin-Lorente AU - Rebecca Kristeleit AU - Helena de la Cueva AU - Nelleke Ottevanger AU - Maria Quindós Varela AU - Hiroyuki Yoshida AU - Theresa Link AU - Lydia Gaba AU - Gloria Marquina AU - Nikki Burdett AU - Paul Johannet AU - Juliane Reichenbach AU - Tjoung-Won Park-Simon AU - Philip H. Klecker AU - Antonio González-Martín AU - Christian Marth AU - Clemens Liebrich AU - Levan Dzotsenidze AU - Sabine Heublein AU - Lawrence Kasherman AU - Cristina Perez AU - Maria Masvidal AU - Pau Guillén Sentís AU - Nikolaus de Gregorio AU - Franziska Hemptenmacher AU - Felix Hilpert AU - Jalid Sehouli AU - Clare Scott AU - Katherine Mary Tucker AU - Jack Dong AU - Cristina Fortuno AU - Amanda B. Spurdle AU - Michael Friedlander AU - Unknown AU - Susan Ellard AU - Anna Tinker AU - Andrew Clamp AU - Iain McNeish AU - Nicoletta Colombo AU - Sandro Pignata AU - Kristina Lindemann AU - Patricia Roxburgh AU - Jae-Weon Kim AU - Shannon Westin AU - Jonathan Berek AU - William Tew AU - Carol Aghajanian AU - Philipp Harter PY - 2026 JO - JAMA Oncology DO - 10.1001/jamaoncol.2026.1924 UR - https://doi.org/10.1001/jamaoncol.2026.1924 ER -
APA
Haggstrom, L., Lee, Y. C., Barretina-Ginesta, M., Jaeger, A., Woelber, L., Woopen, H., Rhind, M., Frenel, J., Aanum, A., Bischof, K., Mongillo, M., Brodsky, A. L., Ledermann, J., Ghezelayagh, T. S., Boere, I., Kaiser, S., Maximiano, C., Rosengarten, O., Safra, T., Pertejo, A., Cecere, S., Ray-Coquard, I., Lheureux, S., Glasspool, R., Gil-Martin, M., Tookman, L., Kim, S. I., Mittelstadt, S., Aparicio, M. C., Palacio, I., Martin-Lorente, C., Kristeleit, R., Cueva, H. D. L., Ottevanger, N., Varela, M. Q., Yoshida, H., Link, T., Gaba, L., Marquina, G., Burdett, N., Johannet, P., Reichenbach, J., Park-Simon, T., Klecker, P. H., González-Martín, A., Marth, C., Liebrich, C., Dzotsenidze, L., Heublein, S., Kasherman, L., Perez, C., Masvidal, M., Sentís, P. G., Gregorio, N. D., Hemptenmacher, F., Hilpert, F., Sehouli, J., Scott, C., Tucker, K. M., Dong, J., Fortuno, C., Spurdle, A. B., Friedlander, M., Unknown, Ellard, S., Tinker, A., Clamp, A., McNeish, I., Colombo, N., Pignata, S., Lindemann, K., Roxburgh, P., Kim, J., Westin, S., Berek, J., Tew, W., Aghajanian, C., & Harter, P. (2026). Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2026.1924
Source records
- crossref · retrieved 2026-09-25T21:02:22.066Z